Page 1 | Search Results | Anesthesiology | American Society of Anesthesiologists

1-20 of 91

Sort by

Sort Order Select

Articles

Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study

Douglas A. Colquhoun, M.B., Ch.B., M.Sc., M.P.H., Sathish Kumar, M.D., Elizabeth Jewell, M.S., Graciela Mentz, Ph.D., Ruth Bickett-Hickok, M.D., Sachin Kheterpal, M.D. M.B.A.

Anesthesiology. September 2024: 141(3):602–607

https://doi.org/10.1097/ALN.0000000000005079

Published: September 2024

View article

Articles

2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade

Stephan R. Thilen, M.D., M.S. (co-chair), Wade A. Weigel, M.D. (co-chair), Michael M. Todd, M.D., Richard P. Dutton, M.D., M.B.A., Cynthia A. Lien, M.D., Stuart A. Grant, M.D., Joseph W. Szokol, M.D., J.D., M.B.A., FASA, Lars I. Eriksson, M.D., Ph.D., FRCA, Myron Yaster, M.D., Mark D. Grant, M.D., Ph.D., Madhulika Agarkar, M.P.H., Anne M. Marbella, M.S., Jaime F. Blanck, M.L.I.S., M.P.A., Karen B. Domino, M.D., M.P.H.

Anesthesiology. January 2023: 138(1):13–41

https://doi.org/10.1097/ALN.0000000000004379

Published: January 2023

View article

Articles

Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative

Wade A. Weigel, M.D., Barbara L. Williams, Ph.D., Neil A. Hanson, M.D., C. Craig Blackmore, M.D., M.P.H., Randy L. Johnson, Cer.A.T., Gary M. Nissen, M.D., Andrew B. James, M.D., Wyndam M. Strodtbeck, M.D.

Anesthesiology. June 2022: 136(6):901–915

https://doi.org/10.1097/ALN.0000000000004174

Published: June 2022

View article

Articles

Postoperative Pulmonary Complications’ Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis

Gen Li, M.Stat., M.Chem., Robert E. Freundlich, M.D., M.S., M.S.C.I., Rajnish K. Gupta, M.D., Christina J. Hayhurst, M.D., Chi H. Le, B.S., Barbara J. Martin, R.N., M.B.A., Matthew S. Shotwell, Ph.D., Jonathan P. Wanderer, M.D., M.Phil., F.A.S.A., F.A.M.I.A.

Anesthesiology. June 2021: 134(6):862–873

https://doi.org/10.1097/ALN.0000000000003735

Published: June 2021

View article

Articles

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis

Sachin Kheterpal, M.D., M.B.A., Michelle T. Vaughn, M.P.H., Timur Z. Dubovoy, M.D., Nirav J. Shah, M.D., Lori D. Bash, Ph.D., M.P.H., Douglas A. Colquhoun, M.B.Ch.B., Amy M. Shanks, Ph.D., Michael R. Mathis, M.D., Roy G. Soto, M.D., Amit Bardia, M.D., Karsten Bartels, M.D., Ph.D., Patrick J. McCormick, M.D., M.Eng., Robert B. Schonberger, M.D., M.H.S., Leif Saager, M.D., M.M.M.

Anesthesiology. June 2020: 132(6):1371–1381

https://doi.org/10.1097/ALN.0000000000003256

Published: June 2020

View article

Articles

Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers

Suzanne J. L. Broens, M.D., Martijn Boon, M.D., Chris H. Martini, M.D., Ph.D., Marieke Niesters, M.D., Ph.D., Monique van Velzen, Ph.D., Leon P. H. J. Aarts, M.D., Ph.D., Albert Dahan, M.D., Ph.D.

Anesthesiology. September 2019: 131(3):467–476

https://doi.org/10.1097/ALN.0000000000002711

Published: September 2019

View article

Articles

How to Catch Unicorns (and Other Fairytales)

Sorin J. Brull, M.D., F.C.A.R.C.S.I. (Hon), Mohamed Naguib, M.D., M.Sc., F.C.A.R.C.S.I.

Anesthesiology. January 2018: 128(1):1–3

https://doi.org/10.1097/ALN.0000000000001959

Published: January 2018

View article

Articles

Neostigmine Administration after Spontaneous Recovery to a Train-of-Four Ratio of 0.9 to 1.0: A Randomized Controlled Trial of the Effect on Neuromuscular and Clinical Recovery

Glenn S. Murphy, M.D., Joseph W. Szokol, M.D., Michael J. Avram, Ph.D., Steven B. Greenberg, M.D., Torin D. Shear, M.D., Mark A. Deshur, M.D., Jessica Benson, B.S., Rebecca L. Newmark, B.A., Colleen E. Maher, B.S.

Anesthesiology. January 2018: 128(1):27–37

https://doi.org/10.1097/ALN.0000000000001893

Published: January 2018

View article

Articles

Epidural Neostigmine versus Fentanyl to Decrease Bupivacaine Use in Patient-controlled Epidural Analgesia during Labor: A Randomized, Double-blind, Controlled Study

Jessica L. Booth, M.D., Vernon H. Ross, M.D., Kenneth E. Nelson, M.D., Lynnette Harris, B.S.N., James C. Eisenach, M.D., Peter H. Pan, M.D.

Anesthesiology. July 2017: 127(1):50–57

https://doi.org/10.1097/ALN.0000000000001669

Published: July 2017

View article

Articles

Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities

Sorin J. Brull, M.D., F.C.A.R.C.S.I. (Hon), Aaron F. Kopman, M.D.

Anesthesiology. January 2017: 126(1):173–190

https://doi.org/10.1097/ALN.0000000000001409

Published: January 2017

View article

Articles

Innovative Disruption in the World of Neuromuscular Blockade: What Is the “State of the Art?”

Mohamed Naguib, M.B., B.Ch., M.Sc., F.C.A.R.C.S.I., M.D., Ken B. Johnson, M.D.

Anesthesiology. January 2017: 126(1):12–15

https://doi.org/10.1097/ALN.0000000000001410

Published: January 2017

View article

Articles

“To Reverse or Not To Reverse?”: The Answer Is Clear!

Glenn S. Murphy, M.D., Aaron F. Kopman, M.D.

Anesthesiology. October 2016: 125(4):611–614

https://doi.org/10.1097/ALN.0000000000001280

Published: October 2016

View article

Articles

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

Catherine M. Bulka, M.P.H., Maxim A. Terekhov, M.S., Barbara J. Martin, R.N., M.B.A., Roger R. Dmochowski, M.D., Rachel M. Hayes, B.S.N., Ph.D., Jesse M. Ehrenfeld, M.D., M.P.H.

Anesthesiology. October 2016: 125(4):647–655

https://doi.org/10.1097/ALN.0000000000001279

Published: October 2016

View article

Articles

Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications

Duncan J. McLean, M.B.Ch.B., Daniel Diaz-Gil, Cand.Med., Hassan N. Farhan, M.B.B.S., Karim S. Ladha, M.D., Tobias Kurth, M.D., Sc.D., Matthias Eikermann, M.D., Ph.D.

Anesthesiology. June 2015: 122(6):1201–1213

https://doi.org/10.1097/ALN.0000000000000674

Published: June 2015

View article

Articles

Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation

Adrienn Pongrácz, M.D., Szilárd Szatmári, M.D., Ph.D., Réka Nemes, M.D., Béla Fülesdi, M.D., Ph.D., D.Sci., Edömér Tassonyi, M.D., Ph.D., D.Sci.

Anesthesiology. July 2013: 119(1):36–42

https://doi.org/10.1097/ALN.0b013e318297ce95

Published: July 2013

View article

Articles

Neostigmine/Glycopyrrolate Administered after Recovery from Neuromuscular Block Increases Upper Airway Collapsibility by Decreasing Genioglossus Muscle Activity in Response to Negative Pharyngeal Pressure

Frank Herbstreit, Dr.med., Daniela Zigrahn, Cand.med., Christof Ochterbeck, Dipl.-Ing., Jürgen Peters, Dr.med., Matthias Eikermann, M.D., Ph.D.

Anesthesiology. December 2010: 113(6):1280–1288

https://doi.org/10.1097/ALN.0b013e3181f70f3d

Published: December 2010

View article

Articles

Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular Block

Stefan J. Schaller, M.D., Heidrun Fink, M.D., Kurt Ulm, Ph.D., Manfred Blobner, M.D.

Anesthesiology. November 2010: 113(5):1054–1060

https://doi.org/10.1097/ALN.0b013e3181f4182a

Published: November 2010

View article

Articles

Neostigmine versus Sugammadex: Which, When, and How Much?

Aaron F. Kopman, M.D.

Anesthesiology. November 2010: 113(5):1010–1011

https://doi.org/10.1097/ALN.0b013e3181f41847

Published: November 2010

View article

Articles

Neostigmine: How Much Is Necessary for Patients Who Receive a Nondepolarizing Neuromuscular Blocking Agent?

Cynthia A. Lien, M.D.

Anesthesiology. January 2010: 112(1):16–18

https://doi.org/10.1097/ALN.0b013e3181c5388f

Published: January 2010

View article

Articles

Antagonism of Low Degrees of Atracurium-induced Neuromuscular Blockade: Dose-Effect Relationship for Neostigmine

Thomas Fuchs-Buder, M.D., Claude Meistelman, M.D., François Alla, M.D., Ph.D., Arnaud Grandjean, M.D., Yann Wuthrich, M.D., François Donati, M.D., Ph.D.

Anesthesiology. January 2010: 112(1):34–40

https://doi.org/10.1097/ALN.0b013e3181c53863

Published: January 2010

View article

NARROW

Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study

2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade

Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative

Postoperative Pulmonary Complications’ Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis

Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers

How to Catch Unicorns (and Other Fairytales)

Neostigmine Administration after Spontaneous Recovery to a Train-of-Four Ratio of 0.9 to 1.0: A Randomized Controlled Trial of the Effect on Neuromuscular and Clinical Recovery

Epidural Neostigmine versus Fentanyl to Decrease Bupivacaine Use in Patient-controlled Epidural Analgesia during Labor: A Randomized, Double-blind, Controlled Study

Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities

Innovative Disruption in the World of Neuromuscular Blockade: What Is the “State of the Art?”

“To Reverse or Not To Reverse?”: The Answer Is Clear!

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications

Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation

Neostigmine/Glycopyrrolate Administered after Recovery from Neuromuscular Block Increases Upper Airway Collapsibility by Decreasing Genioglossus Muscle Activity in Response to Negative Pharyngeal Pressure

Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular Block

Neostigmine versus Sugammadex: Which, When, and How Much?

Neostigmine: How Much Is Necessary for Patients Who Receive a Nondepolarizing Neuromuscular Blocking Agent?

Antagonism of Low Degrees of Atracurium-induced Neuromuscular Blockade: Dose-Effect Relationship for Neostigmine

Email alerts

Email alerts

This Feature Is Available To Subscribers Only